Suppr超能文献

帕金森病的创新:策略与新技术

Innovations in Parkinson's Disease: Strategies and Novel Technologies.

作者信息

Sha Rehan, Dabus Matheus A, Torres-Russotto Diego R, Bhakuni Nila, Dabus Guilherme C

机构信息

Neurosciences, Miami Dade College, Miami, USA.

Neurosciences, Baptist Health South Florida, Miami, USA.

出版信息

Cureus. 2025 Jul 5;17(7):e87309. doi: 10.7759/cureus.87309. eCollection 2025 Jul.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, with its incidence expected to increase significantly in the next few years. Due to its unique pathophysiology and clinical features, the path to early diagnosis and treatment is challenging. Therefore, finding solutions that can address the disease process from every angle, whether improving patients' quality of life or developing new methods for earlier diagnosis and treatment, is important. In this article, we review the pathophysiology of PD and examine the current and new technologies, how they are currently being applied, and the potential impact of their development on the future of Parkinson's research and treatment.

摘要

帕金森病(PD)是第二常见的神经退行性疾病,预计在未来几年其发病率将显著上升。由于其独特的病理生理学和临床特征,早期诊断和治疗面临挑战。因此,找到能够从各个角度应对疾病进程的解决方案,无论是改善患者生活质量还是开发早期诊断和治疗的新方法,都很重要。在本文中,我们回顾了帕金森病的病理生理学,并研究了当前和新技术、它们目前的应用方式以及它们的发展对帕金森病研究和治疗未来的潜在影响。

相似文献

1
Innovations in Parkinson's Disease: Strategies and Novel Technologies.
Cureus. 2025 Jul 5;17(7):e87309. doi: 10.7759/cureus.87309. eCollection 2025 Jul.
2
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
5
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
7
The Views of Healthcare Professionals on iFall, a Smartphone Application for Falls Reporting in Parkinson's Disease: A Qualitative Study.
J Geriatr Psychiatry Neurol. 2025 Feb 1;38(5):8919887251317728. doi: 10.1177/08919887251317728.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes.
J Parkinsons Dis. 2025 Jul 17:1877718X251359391. doi: 10.1177/1877718X251359391.

本文引用的文献

1
Impact of Anticholinergic Burden and Clinical-Demographic Characteristics on Incident Dementia in Parkinson Disease.
J Geriatr Psychiatry Neurol. 2025 Jan 7;38(4):8919887241313376. doi: 10.1177/08919887241313376.
2
From mitochondrial dysfunction to neuroinflammation in Parkinson's disease: Pathogenesis and mitochondrial therapeutic approaches.
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113015. doi: 10.1016/j.intimp.2024.113015. Epub 2024 Sep 1.
4
Assisted technology in Parkinson's disease gait: what's up?
Arq Neuropsiquiatr. 2024 Jun;82(6):1-10. doi: 10.1055/s-0043-1777782. Epub 2024 Feb 23.
6
Using AI to measure Parkinson's disease severity at home.
NPJ Digit Med. 2023 Aug 23;6(1):156. doi: 10.1038/s41746-023-00905-9.
8
Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson's disease.
J Neural Transm (Vienna). 2023 Oct;130(10):1241-1248. doi: 10.1007/s00702-023-02681-y. Epub 2023 Aug 9.
9
The advantages of artificial intelligence-based gait assessment in detecting, predicting, and managing Parkinson's disease.
Front Aging Neurosci. 2023 Jul 12;15:1191378. doi: 10.3389/fnagi.2023.1191378. eCollection 2023.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验